Prognostic values of preoperative platelet-to-lymphocyte ratio, albumin and hemoglobin in patients with non-metastatic colon cancer

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA. 2015;65(2):87–108. doi:10.3322/caac.2126225651787
   PubMedGoogle Scholar
• O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004;96(19):1420–1425. doi:10.1093/jnci/djh27515467030
   PubMed Web of Science ®Google Scholar
• Fichtner-Feigl S, Kesselring R, Strober W. Chronic inflammation and the development of malignancy in the GI tract. Trends Immunol. 2015;36(8):451–459. doi:10.1016/j.it.2015.06.00726194796
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–545. doi:10.1016/S0140-6736(00)04046-011229684
   PubMed Web of Science ®Google Scholar
• Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. The Lancet Oncol. 2014;15(11):e493–503. doi:10.1016/S1470-2045(14)70263-325281468
   PubMed Web of Science ®Google Scholar
• Sun X, Liu X, Liu J, et al. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer. Chin J Cancer. 2016;35(1):57. doi:10.1186/s40880-016-0122-227342313
   PubMedGoogle Scholar
• Chan JC, Chan DL, Diakos CI, et al. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg. 2017;265(3):539–546. doi:10.1097/SLA.000000000000174327070934
   PubMed Web of Science ®Google Scholar
• Lee BM, Chung SY, Chang JS, Lee KJ, Seong J. The neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are prognostic factors in patients with locally advanced pancreatic cancer treated with chemoradiotherapy. Gut Liver. 2018;12(3):342–352. doi:10.5009/gnl1721629409306
   PubMed Web of Science ®Google Scholar
• Peng J, Li H, Ou Q, et al. Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival. Onco Targets Ther. 2017;10:3789–3799. doi:10.2147/OTT.S14087228794643
   PubMed Web of Science ®Google Scholar
• Koh CH, Bhoo-Pathy N, Ng KL, et al. Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer. 2015;113(1):150–158. doi:10.1038/bjc.2015.18326022929
   PubMed Web of Science ®Google Scholar
• Kono SA, Heasley LE, Doebele RC, Camidge DR. Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancer. Curr Cancer Drug Targets. 2012;12(2):107–123.22165970
   PubMed Web of Science ®Google Scholar
• Chen XD, Mao CC, Wu RS, et al. Use of the combination of the preoperative platelet-to-lymphocyte ratio and tumor characteristics to predict peritoneal metastasis in patients with gastric cancer. PLoS One. 2017;12(4):e0175074. doi:10.1371/journal.pone.017507428384215
   PubMed Web of Science ®Google Scholar
• Portale G, Cavallin F, Valdegamberi A, Frigo F, Fiscon V. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio are not prognostic biomarkers in rectal cancer patients with curative resection. J Gastrointestinal Surg. 2018;22:1611–1618. doi:10.1007/s11605-018-3781-2
   PubMed Web of Science ®Google Scholar
• Ge LN, Wang F. Prognostic significance of preoperative serum albumin in epithelial ovarian cancer patients: a systematic review and dose-response meta-analysis of observational studies. Cancer Manag Res. 2018;10:815–825. doi:10.2147/CMAR.S16187629713198
   PubMed Web of Science ®Google Scholar
• Min GT, Wang YH, Yao N, et al. The prognostic role of pretreatment platelet-to-lymphocyte ratio as predictors in patients with colorectal cancer: a meta-analysis. Biomark Med. 2017;11(1):87–97. doi:10.2217/bmm-2016-018127917650
   PubMed Web of Science ®Google Scholar
• Gu XB, Gao XS, Qin SB, et al. Elevated platelet to lymphocyte ratio is associated with poor survival outcomes in patients with colorectal cancer. PLoS One. 2016;11(9). doi:10.1371/journal.pone.0163523
   Web of Science ®Google Scholar
• Zhou X, Du YP, Huang ZB, et al. Prognostic value of PLR in various cancers: a meta-analysis. PLoS One. 2014;9(6):e101119. doi:10.1371/journal.pone.0101119
   Web of Science ®Google Scholar
• Bailon-Cuadrado M, Choolani-Bhojwani E, Tejero-Pintor FJ, et al. Preoperative platelet-lymphocyte ratio is an independent factor of poor prognosis after curative surgery for colon cancer. Updates Surg-Italy. 2018;70(1):33–39. doi:10.1007/s13304-017-0503-3
   PubMed Web of Science ®Google Scholar
• Peng HX, Lin K, He BS, et al. Platelet-to-lymphocyte ratio could be a promising prognostic biomarker for survival of colorectal cancer: a systematic review and meta-analysis. FEBS Open Bio. 2016;6(7):742–750. doi:10.1002/2211-5463.12083
   PubMed Web of Science ®Google Scholar
• Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146(5):1029–1039.7538264
   PubMed Web of Science ®Google Scholar
• Egan K, Crowley D, Smyth P, et al. Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells. PLoS One. 2011;6(10):e26125. doi:10.1371/journal.pone.002612522022533
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Hafner M, Echtenacher B, Mannel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 1999;59(6):1295–1300.10096562
   PubMed Web of Science ®Google Scholar
• Suzuki K, Aiura K, Ueda M, Kitajima M. The influence of platelets on the promotion of invasion by tumor cells and inhibition by antiplatelet agents. Pancreas. 2004;29(2):132–140.15257105
   PubMed Web of Science ®Google Scholar
• Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res. 2002;22(9):913–922. doi:10.1089/1079990026028662312396713
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature0720518650914
   PubMed Web of Science ®Google Scholar
• Menges T, Engel J, Welters I, et al. Changes in blood lymphocyte populations after multiple trauma: association with posttraumatic complications. Crit Care Med. 1999;27(4):733–740.10321662
   PubMed Web of Science ®Google Scholar
• Obermair A, Simunovic M, Isenring L, Janda M. Nutrition interventions in patients with gynecological cancers requiring surgery. Gynecol Oncol. 2017;145(1):192–199. doi:10.1016/j.ygyno.2017.01.02828173966
   PubMed Web of Science ®Google Scholar
• Li SQ, Jiang YH, Lin J, et al. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals. Cancer Med-Us. 2018;7(4):1221–1231. doi:10.1002/cam4.1428
   PubMed Web of Science ®Google Scholar
• Zhang WW, Liu KJ, Ye B, Liang WJ, Ren YZ. Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer. Cancer Med-Us. 2018;7(1):105–113. doi:10.1002/cam4.1270
   PubMed Web of Science ®Google Scholar
• Toiyama Y, Yasuda H, Ohi M, et al. Clinical impact of preoperative albumin to globulin ratio in gastric cancer patients with curative intent. Am J Surg. 2017;213(1):120–126. doi:10.1016/j.amjsurg.2016.05.01227814784
   PubMed Web of Science ®Google Scholar
• Artac M, Uysal M, Karaagac M, et al. Prognostic impact of neutrophil/lymphocyte ratio, platelet count, CRP, and albumin levels in metastatic colorectal cancer patients treated with FOLFIRI-Bevacizumab. J Gastrointest Cancer. 2017;48(2):176–180. doi:10.1007/s12029-016-9879-427714653
   PubMedGoogle Scholar
• Hwang KT, Chung JK, Roh EY, et al. Prognostic influence of preoperative fibrinogen to albumin ratio for breast cancer. J Breast Cancer. 2017;20(3):254–263. doi:10.4048/jbc.2017.20.3.25428970851
   PubMed Web of Science ®Google Scholar
• Ayhan A, Gunakan E, Alyazici I, Haberal N, Altundag O, Dursun P. The preoperative albumin level is an independent prognostic factor for optimally debulked epithelial ovarian cancer. Arch Gynecol Obstet. 2017;296(5):989–995. doi:10.1007/s00404-017-4511-928875365
   PubMed Web of Science ®Google Scholar
• Xiao Y, Ren YK, Cheng HJ, Wang L, Luo SX. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy. Int J Clin Exp Pathol. 2015;8(5):5273–5281.26191228
   PubMed Web of Science ®Google Scholar
• Franco P, Montagnani F, Arcadipane F, et al. The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer. Radiat oncol. 2018;13(1):83. doi:10.1186/s13014-018-1035-929720197
   PubMedGoogle Scholar
• Nordsmark M, Bentzen SM, Rudat V, et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol. 2005;77(1):18–24. doi:10.1016/j.radonc.2005.06.03816098619
   PubMed Web of Science ®Google Scholar
• Vaupel P, Mayer A, Hockel M. Impact of hemoglobin levels on tumor oxygenation: the higher, the better? Strahlenther Onkol. 2006;182(2):63–71. doi:10.1007/s00066-006-1543-716447012
   PubMed Web of Science ®Google Scholar